Efficacy of agomelatine versus venlafaxine on subjective sleep of patients with major depressive disorder

被引：0
|
作者：
Guilleminault, C [1 ]
机构：
[1] Sleep Disorder Clin, Stanford, CA USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S419 / S420
页数：2
相关论文
共 50 条
  • [21] APPLICATION OF ANALYTICAL HIERARCHY PROCESS FOR COMPARING VORTIOXETINE TO AGOMELATINE AND VENLAFAXINE XR IN MAJOR DEPRESSIVE DISORDER
    Briquet, B.
    Diamand, F.
    Francois, C.
    Brignone, M.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A292 - A292
  • [22] EFFICACY AND SAFETY OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER: A PILOT STUDY
    Nukala, Srikrishna
    Komaram, Ravi Babu
    Palla, Jayasree
    Murthy, K. S. N.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (08): : 3517 - 3521
  • [23] Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal
    Singh, Surendra P.
    Singh, Vidhi
    Kar, Nilamadhab
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (03): : 417 - 428
  • [24] Efficacy of agomelatine 25-50 mg in major depressive disorder
    Kennedy, S. H.
    Olie, J. P.
    Loo, H.
    Emsley, R.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S231 - S231
  • [25] Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial
    Corruble, Emmanuelle
    de Bodinat, Christian
    Belaidi, Carole
    Goodwin, Guy M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (10): : 2219 - 2234
  • [26] A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder
    Komaram, Ravi Babu
    Nukala, Srikrishna
    Palla, Jayasree
    Nambaru, Lakshmana Rao
    Kasturi, Satyanarayana Murthy
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (06) : VC5 - VC8
  • [27] The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder: A Placebo-Controlled Study
    Heun, Reinhard
    Ahokas, Antti
    Boyer, Patrice
    Gimenez-Montesinos, Natalia
    Pontes-Soares, Fernando
    Olivier, Valerie
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (06) : 587 - 594
  • [28] Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder
    Kennedy, S.
    Grouin, J.
    Cadour, S.
    Robert, V.
    Picarel-Blanchot, F.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S457 - S458
  • [29] Efficacy of 3 agomelatine dose regimens versus placebo in major depressive disorder (MDD) patients according to the level of severity at baseline
    Kennedy, S. H.
    Avedisova, A.
    Picarel-Blanchot, F.
    De Bodinat, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S408 - S408
  • [30] Agomelatine versus desvenlafaxine versus bupropion XR in the treatment of anhedonia in major depressive disorder
    Romero Guillena, S. L.
    Plasencia Garcia de Diego, B. O.
    Mata Saenz, B. O.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S461 - S462
12345